Dr. Prithvi Reddy Akepati, MD

Dr. Akepati practices at University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico.

Dr. Akepati's NPI, 1932603073, was assigned on March 22, 2018. Dr. Akepati holds New Mexico license MD2024-0146.

Dr. Akepati's primary practice is University of New Mexico Hospital, at 2211 Lomas Boulevard NE, Albuquerque, NM 87106 in Bernalillo County. The practice phone is (505) 272-2111.

Dr. Akepati's primary practice is University of New Mexico Hospital in Albuquerque, New Mexico, part of The University of New Mexico. The medical group on file is UNM Medical Group, Inc. Dmand AI also links Dr. Akepati to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Akepati practices, 2 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Akepati's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Akepati is licensed in New Mexico.

CMS data shows 93 Medicare services from Dr. Akepati across 5 procedure codes in 2024, for 111 Medicare patients. Medicare paid $7,514 for them.

CMS counts 111 Medicare patients who saw Dr. Akepati in 2026. The largest group is 65 to 74, with 57 patients. 63% of them have high blood pressure, and 54% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.47, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Akepati's median patient age at 68, with 56% women.

In 2026, Dr. Akepati wrote 67 Medicare Part D claims for 49 patients. 85% of them were for generic drugs. CMS names the drug for 35 of them, across 2 drugs with 11 or more claims each, at $700 in total drug cost. In 2022, CMS named 180 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 90 out of 100 for Dr. Akepati for performance year 2026, reported as part of a group. Dr. Akepati accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Akepati as offering telehealth. CMS counts 67 procedures of upper gastrointestinal (gi) endoscopy for acid reflux by Dr. Akepati, more than 69% of the clinicians it reports for that procedure.

Dmand AI links 5 papers to Dr. Akepati, published from 2018 to 2025. The most frequent topics are Autophagosomes, Autophagy and Endosomal Sorting Complexes Required for Transport. Dr. Akepati's most frequent co-authors are John L. Berk, MD, Batbold Boldbaatar, MD, PhD and Darrell N. Kotton, MD.

CMS Open Payments shows 16 general payments to Dr. Akepati from 3 drug and device companies from 2022 to 2025. Food and beverage make up the largest share, 100% of the total. Abbvie Inc. paid the most, $309.